Meds During Pregnancy


"I know that people are advised to stop taking many of the stimulants currently prescribed for AD/HD during pregnancy, but what about modafinil, which the FDA may soon approve for treatment of AD/HD?"

Dr. Larry Silver specializes in treating children with attention deficit disorder (ADHD).

Like most AD/HD meds, modafinil is categorized by the FDA as a "Class C" medication. This means that there are no data clearly showing that the medication might cause harm to the fetus and no data showing that it is safe to use.

As opposed to "Class A" (absolutely causes problems) or "Class B" (evidence suggests problems), there is no clear-cut answer. Some obstetricians advise patients not to use any "Class C" medications; some explain possible consequences, but believe it's OK. This is an individual decision you must make based on a conversation with your obstetrician.

Larry Silver, M.D., is clinical professor of psychiatry at Georgetown Medical Center in Washington, D.C. and director of training in child and adolescent psychiatry at Georgetown University School of Medicine. He is a former acting director and deputy director of the National Institute of Mental Health, as well as the author of Dr. Larry Silver's Advice to Parents on AD/HD and The Misunderstood Child: Understanding and Coping with Your Child's Learning Disabilities.
Copyright © 1998 - 2016 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 108 West 39th Street, Suite 805, New York, NY 10018